HI
INO icon

Hudock Inc’s Inovio Pharmaceuticals INO Stock Holding History

Hudock Inc’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1
Closed – – 406
2022
Q3 		$0 Hold
1
– – ﹤0.01% 773
2022
Q2 		$0 Hold
1
– – ﹤0.01% 769
2022
Q1 		$0 Hold
1
– – ﹤0.01% 769
2021
Q4 		$0 Hold
1
– – ﹤0.01% 809
2021
Q3 		$0 Hold
1
– – ﹤0.01% 863
2021
Q2 		$0 Hold
1
– – ﹤0.01% 830
2021
Q1 		$0 Hold
1
– – ﹤0.01% 819
2020
Q4 		$0 Buy
+1
New +$133 ﹤0.01% 768
2020
Q2 		– Sell
-52
Closed -$4K – 747
2020
Q1 		$4K Buy
+52
New +$3.21K ﹤0.01% 497

Other funds holding INO

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hudock Inc's INO Position: Q4 2022 in Review

Hudock Inc sold out of Inovio Pharmaceuticals (INO) in Q4 2022, closing a stake of 1 share.

Hudock Inc first reported a position in INO in Q1 2020 and held it in 9 quarters. The position peaked at $4K in Q1 2020. 183 funds tracked by Wall St. Rank hold INO as of Q4 2022.

  • Hudock Inc reported no remaining Inovio Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Hudock Inc sold 1 Inovio Pharmaceuticals share in Q4 2022.
  • Hudock Inc first reported a position in Inovio Pharmaceuticals in Q1 2020 and held it in 9 quarters.
  • Hudock Inc's Inovio Pharmaceuticals position peaked at $4K in Q1 2020.
  • 183 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2022.

Based on Hudock Inc's 13F filing for Q4 2022, filed 8 Feb 2023.